Therapeutic Targeting of mTOR in T-Cell Acute Lymphoblastic Leukemia: An Update

T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive blood malignancy that arises from the clonal expansion of transformed T-cell precursors. Although T-ALL prognosis has significantly improved due to the development of intensive chemotherapeutic protocols, primary drug-resistant and relapse...

Descripción completa

Detalles Bibliográficos
Autores principales: Evangelisti, Camilla, Chiarini, Francesca, McCubrey, James A., Martelli, Alberto M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6073309/
https://www.ncbi.nlm.nih.gov/pubmed/29949919
http://dx.doi.org/10.3390/ijms19071878

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6073309/
https://www.ncbi.nlm.nih.gov/pubmed/29949919
http://dx.doi.org/10.3390/ijms19071878

Ejemplares similares